192 related articles for article (PubMed ID: 34348275)
41. Prolonged cholestasis triggered by hepatitis A virus infection and variants of the hepatocanalicular phospholipid and bile salt transporters.
Krawczyk M; Grünhage F; Langhirt M; Bohle RM; Lammert F
Ann Hepatol; 2012; 11(5):710-4. PubMed ID: 22947535
[TBL] [Abstract][Full Text] [Related]
42. Molecular and computational characterization of ABCB11 and ABCG5 variants in Tunisian patients with neonatal/infantile low-GGT intrahepatic cholestasis: Genetic diagnosis and genotype-phenotype correlation assessment.
Khabou B; Kallabi F; Abdelaziz RB; Maaloul I; Aloulou H; Chehida AB; Kammoun T; Barbu V; Boudawara TS; Fakhfakh F; Khemakhem B; Sahnoun OS
Ann Hum Genet; 2024 May; 88(3):194-211. PubMed ID: 38108658
[TBL] [Abstract][Full Text] [Related]
43. ABCB4 gene mutations and single-nucleotide polymorphisms in women with intrahepatic cholestasis of pregnancy.
Bacq Y; Gendrot C; Perrotin F; Lefrou L; Chrétien S; Vie-Buret V; Brechot MC; Andres CR
J Med Genet; 2009 Oct; 46(10):711-5. PubMed ID: 19584064
[TBL] [Abstract][Full Text] [Related]
44. Biliary transporter gene mutations in severe intrahepatic cholestasis of pregnancy: Diagnostic and management implications.
Yeap SP; Harley H; Thompson R; Williamson KD; Bate J; Sethna F; Farrell G; Hague WB
J Gastroenterol Hepatol; 2019 Feb; 34(2):425-435. PubMed ID: 29992621
[TBL] [Abstract][Full Text] [Related]
45. Variants in ABCB4 (MDR3) across the spectrum of cholestatic liver diseases in adults.
Stättermayer AF; Halilbasic E; Wrba F; Ferenci P; Trauner M
J Hepatol; 2020 Sep; 73(3):651-663. PubMed ID: 32376413
[TBL] [Abstract][Full Text] [Related]
46. Severe hepatocellular dysfunction in obstetric cholestasis related to combined genetic variation in hepatobiliary transporters.
Zimmer V; Krawczyk M; Mahler M; Weber SN; Müllenbach R; Lammert F
Clin Exp Obstet Gynecol; 2012; 39(1):32-5. PubMed ID: 22675952
[TBL] [Abstract][Full Text] [Related]
47. Genetic variant c.711A>T in the hepatobiliary phospholipid transporter ABCB4 is associated with significant liver fibrosis.
Smyk W; Weber SN; Hall R; Gruenhage F; Lammert F; Krawczyk M
J Physiol Pharmacol; 2020 Jun; 71(3):. PubMed ID: 32991311
[TBL] [Abstract][Full Text] [Related]
48. ABCB4 disease: Many faces of one gene deficiency.
Sticova E; Jirsa M
Ann Hepatol; 2020; 19(2):126-133. PubMed ID: 31759867
[TBL] [Abstract][Full Text] [Related]
49. ABCB11 gene mutations in Chinese children with progressive intrahepatic cholestasis and low gamma glutamyltransferase.
Liu LY; Wang ZL; Wang XH; Zhu QR; Wang JS
Liver Int; 2010 Jul; 30(6):809-15. PubMed ID: 19845854
[TBL] [Abstract][Full Text] [Related]
50. Antisense oligonucleotides rescue an intronic splicing variant in the ABCB11 gene that causes progressive familial intrahepatic cholestasis type 2.
Zheng Y; Zhou C; Zheng B; Hu G; Wang C; Zhou W; Lu Y; Zhang Z; Lin Q; Guo H; Jin Y; Liu Z; Tang W
Dig Liver Dis; 2022 Nov; 54(11):1541-1547. PubMed ID: 35490150
[TBL] [Abstract][Full Text] [Related]
51. [Childhood cholestasis and bile transporters].
Hierro L; Jara P
Gastroenterol Hepatol; 2005; 28(7):388-95. PubMed ID: 16137474
[TBL] [Abstract][Full Text] [Related]
52. Contribution of variant alleles of ABCB11 to susceptibility to intrahepatic cholestasis of pregnancy.
Dixon PH; van Mil SW; Chambers J; Strautnieks S; Thompson RJ; Lammert F; Kubitz R; Keitel V; Glantz A; Mattsson LA; Marschall HU; Molokhia M; Moore GE; Linton KJ; Williamson C
Gut; 2009 Apr; 58(4):537-44. PubMed ID: 18987030
[TBL] [Abstract][Full Text] [Related]
53. New Insights in Genetic Cholestasis: From Molecular Mechanisms to Clinical Implications.
Sticova E; Jirsa M; Pawłowska J
Can J Gastroenterol Hepatol; 2018; 2018():2313675. PubMed ID: 30148122
[TBL] [Abstract][Full Text] [Related]
54. Functional analysis of the correlation between ABCB11 gene mutation and primary intrahepatic stone.
Gan L; Pan S; Cui J; Bai J; Jiang P; He Y
Mol Med Rep; 2019 Jan; 19(1):195-204. PubMed ID: 30431138
[TBL] [Abstract][Full Text] [Related]
55. ABCB4 Gene Aberrations in Human Liver Disease: An Evolving Spectrum.
Reichert MC; Lammert F
Semin Liver Dis; 2018 Nov; 38(4):299-307. PubMed ID: 30357767
[TBL] [Abstract][Full Text] [Related]
56. No contribution of the ABCB11 p.444A polymorphism in Japanese patients with drug-induced cholestasis.
Kagawa T; Hirose S; Arase Y; Oka A; Anzai K; Tsuruya K; Shiraishi K; Orii R; Ieda S; Nakazawa T; Tomita K; Hokari R; Miura S; Ebinuma H; Saito H; Kitamura T; Horie Y; Okuse C; Wasada M; Inoko H; Tohkin M; Saito Y; Maekawa K; Takikawa H; Mine T
Drug Metab Dispos; 2015 May; 43(5):691-7. PubMed ID: 25713208
[TBL] [Abstract][Full Text] [Related]
57. Genetic determinants of drug-induced cholestasis and intrahepatic cholestasis of pregnancy.
Pauli-Magnus C; Meier PJ; Stieger B
Semin Liver Dis; 2010 May; 30(2):147-59. PubMed ID: 20422497
[TBL] [Abstract][Full Text] [Related]
58. Autoimmune BSEP disease: disease recurrence after liver transplantation for progressive familial intrahepatic cholestasis.
Kubitz R; Dröge C; Kluge S; Stross C; Walter N; Keitel V; Häussinger D; Stindt J
Clin Rev Allergy Immunol; 2015 Jun; 48(2-3):273-84. PubMed ID: 25342496
[TBL] [Abstract][Full Text] [Related]
59. Comprehensive bile acid profiling in hereditary intrahepatic cholestasis: Genetic and clinical correlations.
Liu T; Wang RX; Han J; Hao CZ; Qiu YL; Yan YY; Li LT; Wang NL; Gong JY; Lu Y; Zhang MH; Xie XB; Yang JC; You YJ; Li JQ; Knisely AS; Borchers CH; Ling V; Wang JS
Liver Int; 2018 Sep; 38(9):1676-1685. PubMed ID: 29412511
[TBL] [Abstract][Full Text] [Related]
60. Benign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB11.
van Mil SW; van der Woerd WL; van der Brugge G; Sturm E; Jansen PL; Bull LN; van den Berg IE; Berger R; Houwen RH; Klomp LW
Gastroenterology; 2004 Aug; 127(2):379-84. PubMed ID: 15300568
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
